|
Flutamide EP Impurity D（Niflumic Acid EP Impurity C）
|
氟他胺EP雜質(zhì)D(硝氟酸EP雜質(zhì)C)
|
98-16-8
|
|
Relugolix Impurity 82
|
瑞盧戈利雜質(zhì)82
|
|
|
Dapagliflozin Impurity 27
|
達格列凈雜質(zhì)27
|
|
|
Naltrexone EP Impurity G
|
納曲酮EP雜質(zhì)G
|
|
|
Glimepiride EP impurity G
|
格列美脲EP雜質(zhì)G
|
|
|
Benzylpenicillin (Benzathine)tetrahydrate EP Impurity C
|
四水合芐基青霉素（芐硫醚）EP雜質(zhì)C
|
|
|
Cefprozil EP Impurity K1
|
頭孢丙烯EP雜質(zhì)K1(異構(gòu)體）
|
|
|
L-Cefprozil hydrate
|
L-頭孢丙烯（頭孢丙烯雜質(zhì)2）
|
|
|
Fusidic Acid EP Impurity C
|
夫西地酸EP雜質(zhì)C
|
|
|
Urapidil Impurity 40
|
烏拉地爾雜質(zhì)40
|
|
|
Urapidil Impurity 33
|
烏拉地爾雜質(zhì)33
|
|
|
Fluticasone Furoate EP Impurity I
|
糠酸氟替卡松EP雜質(zhì)I
|
|
|
Labetalol EP Impurity E
|
拉貝洛爾EP雜質(zhì)E
|
|
|
Fusidic Acid EP Impurity D
|
夫西地酸EP雜質(zhì)D
|
|
|
Topiramate Impurity 20
|
托吡酯雜質(zhì)20
|
|
|
Ornithine Impurity 11
|
鳥氨酸雜質(zhì)11
|
7327-72-2
|
|
Blonanserin Impurity 8
|
布南色林雜質(zhì)8
|
|
|
Dabigatran impurity 80
|
達比加群雜質(zhì)80
|
1307233-94-8
|
|
Cefprozil EP Impurity K4
|
頭孢丙烯EP雜質(zhì)K4(異構(gòu)體）
|
|
|
Trimethoxycefalexin (USP)
|
甲氧基頭孢羥氨芐(USP)
|
|
|
Urapidil Impurity 39
|
烏拉地爾雜質(zhì)39
|
|
|
Amoxicillin Impurity 47
|
阿莫西林雜質(zhì)47
|
|
|
Ambroxol Impurity 27 HCl
|
氨溴索雜質(zhì)27鹽酸鹽
|
|
|
Mometasone Furoate Impurity T
|
糠酸莫米松EP雜質(zhì)T
|
|
|
Pyridoxine Impurity 30
|
吡哆醇雜質(zhì)30
|
|
|
Travoprost 10
|
曲伏前列素雜質(zhì)10
|
2218532-68-2
|
|
Travoprost 9
|
曲伏前列素雜質(zhì)9
|
|
|
Travoprost 11
|
曲伏前列素雜質(zhì)11
|
2218532-66-0
|
|
Moxifloxacin related substance e (designated brand USP cat. No. 1448655)
|
莫西沙星相關(guān)物質(zhì)E(指定品牌USP 貨號1448655）
|
|
|
Travoprost 6
|
曲伏前列素雜質(zhì)6
|
|
|
Prilocaine impurity E (designated brand EP cat. No. p2939025)
|
丙胺卡因雜質(zhì)E（指定品牌EP 貨號P2939025）
|
|
|
Lifitegrast Impurity 54
|
立他司特雜質(zhì)54
|
|
|
Cefmetazole S-Methyl Sodium salt
|
頭孢美唑硫甲基鈉鹽（頭孢美唑雜質(zhì)40）
|
|
|
Lifitegrast Impurity 55
|
立他司特雜質(zhì)55
|
|
|
Brimonidine Dimer Impurity
|
溴莫尼定二聚體雜質(zhì)
|
|
|
Benserazide Impurity 4 HCI
|
芐絲肼雜質(zhì)4鹽酸鹽
|
|
|
D-p-hydroxyphenylglycine methyl ester
|
D-對羥基苯甘氨酸甲酯
|
|
|
Bortezomib Impurity P
|
硼替佐米雜質(zhì)P
|
|
|
Ornithine Impurity 15
|
鳥氨酸雜質(zhì)15
|
|
|
Cefprozil EP Impurity L
|
頭孢丙烯EP雜質(zhì)L
|
|
|
Sorafenib related compound 29
|
索拉非尼相關(guān)化合物29
|
|
|
Mometasone Furoate Impurity I
|
糠酸莫米松EP雜質(zhì)I
|
|
|
Sorafenib related compound 30
|
索拉非尼相關(guān)化合物30
|
|
|
Ornithine Impurity 16
|
鳥氨酸雜質(zhì)16
|
|
|
Cefprozil EP Impurity K3
|
頭孢丙烯EP雜質(zhì)K3(異構(gòu)體）
|
|
|
Cefcapene pivoxil Impurity 5
|
頭孢卡品酯雜質(zhì)5
|
|
|
Deferiprone EP impurity C
|
去鐵酮EP雜質(zhì)C
|
|
|
Cefcapene pivoxil Impurity 8
|
頭孢卡品酯雜質(zhì)8
|
|
|
Prilocaine hydrochloride - d7
|
鹽酸丙胺卡因-d7（丙胺卡因雜質(zhì)29）
|
|
|
Fusidic Acid EP Impurity E
|
夫西地酸EP雜質(zhì)E
|
|
|
Dapagliflozin Impurity 32
|
達格列凈雜質(zhì)32
|
|
|
Tinidazole Denitrification Impurity
|
替硝唑去硝基雜質(zhì)
|
|
|
heptan-2-yl carbonochloridate
|
庚烷-2-羰基氯化物
|
|
|
Lifitegrast Impurity 38
|
立他司特雜質(zhì)38
|
|
|
Relugolix Impurity 83
|
瑞盧戈利雜質(zhì)83
|
|
|
Fluticasone Propionate EP Impurity J
|
丙酸氟替卡松EP雜質(zhì)J
|
|
|
Sodium Salvia miltiorrhiza mesylate
|
紫丹參甲素磺酸鈉（丹參酮IIA雜質(zhì)4）
|
|
|
Sodium tanshinone Ⅱ B sulfonate
|
丹參酮ⅡB磺酸鈉（丹參酮ⅡB雜質(zhì)2）
|
|
|
Drotaverine Impurity 33
|
屈他維林雜質(zhì)33
|
|
|
Peramivir Dimer Impurity 1
|
帕拉米韋二聚體雜質(zhì)1
|
|
|
Ticagrelor Impurity O
|
替格瑞洛雜質(zhì)O
|
|
|
Cefprozil δ- Isomer at position 3 (USP
|
頭孢丙烯δ-3位異構(gòu)體（USP）
|
|
|
Cefprozil amino compound (USP)
|
頭孢丙烯氨基化合物（USP)
|
|
|
Sulfasalazine IMP-K USP / EP
|
柳氮磺胺吡啶IMP-K USP / EP
|
|
|
L-p-hydroxyphenylglycine methyl ester
|
L-對羥基苯甘氨酸甲酯
|
127369-30-6
|
|
Palbociclib Impurity Y
|
帕布昔利布雜質(zhì)Y
|
2174002-16-3
|
|
Acyclovir mixture / C (cat. No. y0002242)
|
阿昔洛韋混合物/C(貨號Y0002242）
|
|
|
Ilaprazole Impurity 32
|
艾普拉唑雜質(zhì)32
|
|
|
Acyclovir for system suitability / a (cat. No. y0002245)
|
阿昔洛韋用于系統(tǒng)適用性/A(貨號Y0002245)
|
|
|
Biapenem Impurity 12
|
比阿培南雜質(zhì)12
|
|
|
Bumetanide Impurity 36
|
布美他尼雜質(zhì)36
|
|
|
Ilaprazole Impurity 38
|
艾普拉唑雜質(zhì)38
|
|
|
Edoxaban Impurity 90
|
依度沙班雜質(zhì)90
|
|
|
Oxacillin Impurity 7
|
苯唑西林雜質(zhì)7
|
94419-27-9
|
|
Ilaprazole Impurity 37
|
艾普拉唑雜質(zhì)37
|
|
|
Salbutamol glyoxal
|
沙丁胺醇乙二醛
|
|
|
Epalrestat Impurity E
|
依帕司他雜質(zhì)E
|
|
|
Sodium 3-hydroxytanshinone IIA sulfonate
|
3-羥基丹參酮IIA磺酸鈉（丹參酮IIA雜質(zhì)3）
|
|
|
Dexrazoxane Impurity 28
|
右雷佐生(右丙亞胺)雜質(zhì)28
|
|
|
Cefprozil EP Impurity K2
|
頭孢丙烯EP雜質(zhì)K2(異構(gòu)體）
|
|
|
Gliclazide EP Impurity G
|
格列齊特EP雜質(zhì)G
|
|
|
Tinidazole Impurity 4
|
替硝唑雜質(zhì)4
|
|
|
Dapoxetine Impurity 61
|
達泊西汀雜質(zhì)61
|
|
|
Sorafenib related compound 28
|
索拉非尼相關(guān)化合物28
|
|
|
Cefmetazole Double Bond Isomer Impurity
|
頭孢美唑雙鍵異構(gòu)體雜質(zhì)（頭孢美唑雜質(zhì)39）
|
|
|
Ofloxacin impurity D (designated brand EP cat. No. y0002202)
|
氧氟沙星雜質(zhì)D（指定品牌EP 貨號Y0002202）
|
|
|
Mometasone Furoate Impurity P
|
糠酸莫米松EP雜質(zhì)P
|
|
|
Isoproterenol Impurity 7
|
異丙腎上腺素雜質(zhì)7
|
|
|
Dabigatran impurity 81
|
達比加群雜質(zhì)81
|
211915-07-0
|
|
Sodium 1-hydroxytanshinone Ⅱ a sulfonate
|
1- 羥基丹參酮ⅡA 磺酸鈉(丹參酮ⅡA雜質(zhì)1）
|
|
|
Topiramate Impurity 19
|
托吡酯雜質(zhì)19
|
|
|
Tinidazole Impurity 9
|
替硝唑雜質(zhì)9
|
|
|
β-D-Arabinofuranose 9H-PurinoDiacetate
|
β-D-阿拉伯呋喃糖9H嘌呤二乙酸酯
|
|
|
Urapidil Impurity 31
|
烏拉地爾雜質(zhì)31
|
|
|
Benzylpenicillin (Benzathine) tetrahydrate EP Impurity K
|
四水合芐基青霉素（芐硫醚）EP雜質(zhì)K
|
|
|
Nicergoline EP Impurity E
|
尼麥角林EP雜質(zhì)E
|
|
|
Relugolix Impurity 80
|
瑞盧戈利雜質(zhì)80
|
|
|
Ilaprazole Impurity 36
|
艾普拉唑雜質(zhì)36
|
|
|
Bortezomib Impurity 5
|
硼替佐米雜質(zhì)5
|
2379402-85-2
|
|
Relugolix Impurity 85
|
瑞盧戈利雜質(zhì)85
|
|
|
Isavuconazole Impurity 33
|
艾沙康唑雜質(zhì)33
|
|